Fireflies are hard to miss in Michigan. What to know as they light up backyards
Fireflies (or lightning bugs) prefer hot and humid weather. They emerge when temperatures become warm typically around May or mid-June. Residents can expect to see more fireflies over the summer after a mild winter and a rainy spring, according to the Farmers' Almanac. At dusk or later in the night they become active creating quite the spectacle.
Their ability to create light is credited to a process called bioluminescence. Fireflies can control the chemical reaction inside their light organ located in their lower abdomen.
Species of jellyfish, shrimp, shark, squid and other marine animal share the same ability.
According to NC State University, fireflies use bioluminescence to intimidate predators, attract a mate and even communicate.
In North America, there are hundreds of firefly species with three main groups, called photinus, pyractomena and photuris, based on Mass Audubon, and they vary in size and even the color of their light. For example, pyractomena fireflies flash an amber color, while photinus flash a yellow-green.
Though fireflies are frequent in Michigan this summer, their populations overall are threatened due to habitat loss and light pollution, according to Xerces Society for Invertebrate Conservation.
As fireflies continue to flash, sparkle and possibly inspire a child-like wonder, here's more on these species in Michigan:
Why do fireflies light up?
Fireflies communicate via flashes of their light to attract mates, deter predators or claim territory, according to Firefly Conservation and Research.
Flashes are unique to firefly species, though the photinus carolinus fireflies flash in synchronization — a rare, temporary behavior that occurs during the summertime, and previously observed in many national parks.
"Each species of firefly has its own pattern. Many fireflies look similar, so these flash patterns help to identify particular firefly species," Mass Audubon said.
Both male and female fireflies have the ability to create light, though to tell them apart, males have a larger light organ covering two segments of their bodies, while females' light organs are typically smaller.
Are fireflies a beetle?
Yes, fireflies are beetles and they belong to the insect order called coleoptera and the insect family called Lampyridae — which means "to shine," in Greek, according to Michigan State University's Extension.
Like other species of beetles, fireflies have two pairs of wings with a shell-like covering to protect their wings, so while they are flying, their shell is raised upward to let their wings flap freely.
Do fireflies bite?
No, fireflies do not bite or sting humans. However, they may become a nuisance if a few accidently enter your house. According to pest control company Orkin, to keep fireflies out of your home, remove or reduce outdoor lightning so they only have their bioluminescence to rely on.
What do fireflies eat?
Fireflies are a predatory beetle and eat other insects like snails, slugs or worms. They go through a lengthy life cycle (up to 3 years) and spend most of their life in the larval stage underground, and at this stage they are "eating machines," according to MSU's Extension.
Not only do they have an appetite, but they have a fierce hunting strategy. According to Firefly Atlas, they inject a paralyzing neurotoxin into their prey then emit a digestive enzyme to liquefy them before eating.
Why are firefly populations going down?
According to Firefly Conservation and Research, the main factors disrupting firefly numbers are habitat loss and light pollution.
"Scientists have observed that synchronous fireflies get out of synch for a few minutes after a car's headlights pass," the research-based organization said. "Light from homes, cars, stores, and streetlights may all make it difficult for fireflies to signal each other during mating — meaning fewer firefly larvae are born next season," the organization said."
Here are a few ways to help steady their populations from your backyard:
Turn off outdoor lighting
Create a firefly habitat
Avoid using pesticides or weed killers
Plant native trees, like pine trees
In addition, people may report their firefly sightings to help track their distribution nationally. Firefly Atlas, a conservation organization, features a tracker for members (after creating an account) to submit their sightings.
Contact Sarah Moore @ smoore@lsj.com
This article originally appeared on Lansing State Journal: Fireflies in Michigan: What to know about their glow, life cycle
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Canadian researchers create tool to remove anti-deepfake watermarks from AI content
OTTAWA — University of Waterloo researchers have built a tool that can quickly remove watermarks identifying content as artificially generated — and they say it proves that global efforts to combat deepfakes are most likely on the wrong track. Academia and industry have focused on watermarking as the best way to fight deepfakes and "basically abandoned all other approaches," said Andre Kassis, a PhD candidate in computer science who led the research. At a White House event in 2023, the leading AI companies — including OpenAI, Meta, Google and Amazon — pledged to implement mechanisms such as watermarking to clearly identify AI-generated content. AI companies' systems embed a watermark, which is a hidden signature or pattern that isn't visible to a person but can be identified by another system, Kassis explained. He said the research shows the use of watermarks is most likely not a viable shield against the hazards posed by AI content. "It tells us that the danger of deepfakes is something that we don't even have the tools to start tackling at this point," he said. The tool developed at the University of Waterloo, called UnMarker, follows other academic research on removing watermarks. That includes work at the University of Maryland, a collaboration between researchers at the University of California and Carnegie Mellon, and work at ETH Zürich. Kassis said his research goes further than earlier efforts and is the "first to expose a systemic vulnerability that undermines the very premise of watermarking as a defence against deepfakes." In a follow-up email statement, he said that "what sets UnMarker apart is that it requires no knowledge of the watermarking algorithm, no access to internal parameters, and no interaction with the detector at all." When tested, the tool worked more than 50 per cent of the time on different AI models, a university press release said. AI systems can be misused to create deepfakes, spread misinformation and perpetrate scams — creating a need for a reliable way to identify content as AI-generated, Kassis said. After AI tools became too advanced for AI detectors to work well, attention turned to watermarking. The idea is that if we cannot "post facto understand or detect what's real and what's not," it's possible to inject "some kind of hidden signature or some kind of hidden pattern" earlier on, when the content is created, Kassis said. The European Union's AI Act requires providers of systems that put out large quantities of synthetic content to implement techniques and methods to make AI-generated or manipulated content identifiable, such as watermarks. In Canada, a voluntary code of conduct launched by the federal government in 2023 requires those behind AI systems to develop and implement "a reliable and freely available method to detect content generated by the system, with a near-term focus on audio-visual content (e.g., watermarking)." Kassis said UnMarker can remove watermarks without knowing anything about the system that generated it, or anything about the watermark itself. "We can just apply this tool and within two minutes max, it will output an image that is visually identical to the watermark image" which can then be distributed, he said. "It kind of is ironic that there's billions that are being poured into this technology and then, just with two buttons that you press, you can just get an image that is watermark-free." Kassis said that while the major AI players are racing to implement watermarking technology, more effort should be put into finding alternative solutions. Watermarks have "been declared as the de facto standard for future defence against these systems," he said. "I guess it's a call for everyone to take a step back and then try to think about this problem again." This report by The Canadian Press was first published July 23, 2025. Anja Karadeglija, The Canadian Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Male birth control pill passes early safety test, with more trials underway
When you buy through links on our articles, Future and its syndication partners may earn a commission. An experimental, hormone-free male birth control pill has just passed its first safety test in humans. The trial included 16 people and was only intended to test whether the drug reached adequate levels in the body, as well as whether it triggered any serious side effects, such as concerning changes in heart rate, hormone function, inflammation, mood or sexual function. Across the doses tested, no significant side effects were observed. That result tees up the pill to be tested in larger trials that will now look at both safety and efficacy. The results of the early safety trial, published Tuesday (July 22) in the journal Communications Medicine, are a critical first step toward getting the pill approved, Dr. Stephanie Page, an endocrinologist at the University of Washington School of Medicine who wasn't involved in the study, told Scientific American. "We really need more reversible contraceptive methods for men," she added. For the moment, the only male birth control options are condoms and vasectomies. The latter can be reversed, but the actual success rate of the reversal procedure varies widely in terms of how likely a person is to conceive a child afterward. If approved, the new pill would be the first drug in its class. "A safe and effective male pill will provide more options to couples for birth control," Gunda Georg, a professor in the University of Minnesota College of Pharmacy, where the drug molecule was developed, said in a statement released earlier this year following promising preclinical testing of the pill. Columbia University was also involved in the drug's development, along with the company YourChoice Therapeutics, which is overseeing the trials. Related: Why is there still no male birth control pill? "It will allow a more equitable sharing of responsibility for family planning and provide reproductive autonomy for men," Georg said. How the male birth control pill works The experimental pill, called YCT-529, is designed to pause sperm production by interrupting specific signals in the body. Specifically, the drug works by blocking a protein called "retinoic acid receptor alpha," which is known to play a key role in the formation and maturation of sperm. In the testes, the receptor would usually be activated by the insertion of a "key" — a vitamin A metabolite — but the drug stops this key from clicking into place. That, in turn, prevents the chain reaction that ends with sperm being made. Finding a compound with this effect required the scientists to closely examine the structure of the receptor when it's bound to its key, as well as test dozens of molecules to see which could block the interaction. In preclinical tests with male lab mice, the drug "elicited profound effects" on sperm production. It triggered reversible infertility within four weeks of use, showing 99% effectiveness at preventing pregnancy in the female mice the treated males mated with. When taken off the drug, the male mice's fertility was restored within about four to six weeks. Further tests in nonhuman primates returned similar results, with sperm counts falling dramatically within two weeks of starting the drug and fully recovering within 10 to 15 weeks of stopping the drug. These preclinical tests set the stage for the recent clinical trial in people. The trial included 16 males ages 32 to 59, all of whom had previously undergone vasectomies. This was done out of an abundance of caution, in case the experimental drug was to have any lasting impacts on fertility, Nadja Mannowetz, co-founder and chief science officer of YourChoice Therapeutics, told Scientific American. The participants were split into groups who received either placebo pills or a low or high dose of the drug. Most of the participants took the pill only after a period of fasting, but a subset were also given doses after a large meal, to see if that affected levels of the drug in the body. Across all of the doses and conditions tested, the levels of the drug in the body reached decent levels, but Mannowetz anticipates that, if approved, the final dose would be closest to the highest one tested: 180 milligrams. RELATED STORIES —Hormonal birth control may double risk of stroke, study finds —1st over-the-counter birth control pill approved by FDA —Blood clot risk linked to taking common painkillers alongside certain hormonal birth control Both the animal study and the human trial results suggest that the approved pill would likely be taken once a day, but further trials will confirm that dosing. And although no notable side effects emerged in this small trial, future trials with larger study cohorts will still need to monitor for these effects. "The positive results from this first clinical trial laid the groundwork for a second trial, where men receive YCT-529 for 28 days and 90 days, to study safety and changes in sperm parameters," the study authors wrote in their paper. That trial is already underway and again is looking at males who have already had vasectomies or who have made a firm decision not to father children. This article is for informational purposes only and is not meant to offer medical advice.
Medscape
2 hours ago
- Medscape
How Myeloma Plays Hide and Seek With CAR T Cells
TOPLINE: G protein-coupled receptor, class C, group 5, member D (GPRC5D) loss after chimeric antigen receptor (CAR) T-cell therapy in multiple myeloma (MM) occurs through biallelic genetic inactivation and hypermethylation-driven epigenetic silencing. Among 10 patients who relapsed, eight showed GPRC5D loss, while two had mixed expression. METHODOLOGY: Researchers conducted whole-genome sequencing (WGS) and whole-genome bisulfite sequencing (WGBS) analysis on MM samples from 10 patients who relapsed after GPRC5D CAR T-cell therapy. Analysis included CD138+ MM cells isolated from bone marrow samples with purity exceeding 80%, with tumor samples sequenced at 100× coverage and matched normal samples at 30× coverage. Investigators performed targeted bisulfite sequencing to evaluate methylation status of GPRC5D regulatory regions across seven MM cell lines, with library construction and sequencing conducted by specialized institutes. Patient characteristics included median age of 57.5 years (range, 44-66 years), equal gender distribution, and 90% having high-risk cytogenetic abnormalities. TAKEAWAY: Genetic alterations were identified in three cases: one with homozygous deletion in GPRC5D gene, another with biallelic loss in regulatory regions, and a third with homozygous deletions in both TNFRSF17 and GPRC5D after sequential anti-B-cell maturation antigen and anti-GPRC5D CAR T-cell therapies. Multiple hypermethylation sites were present in transcriptional regulatory elements of GPRC5D gene in five posttreatment MM samples, with no genetic changes detected at GPRC5D locus in seven cases. GPRC5D expression showed inverse correlation with methylation levels in regulatory regions of MM cell lines, with azacitidine treatment inducing GPRC5D messenger RNA and protein expression in hypermethylated MM cell lines. All 10 patients achieved complete response or better as best response with median time to best response of 2.5 months (range, 0.5-15.3 months), though median time to disease progression was 15.9 months (range, 3.0-26.5 months). IN PRACTICE: 'Our findings highlight that biallelic genetic inactivation and hypermethylation-driven epigenetic silencing are key mechanisms contributing to GPRC5D loss and treatment resistance,' wrote the authors of the study. SOURCE: The study was led by Mingshan Niu, Blood Diseases Institute, Xuzhou Medical University in Xuzhou, China. It was published online in Blood. LIMITATIONS: According to the authors, the structural variant deletions on chromosomes may be missed by 100× WGS in patients with a clone size less than 20%. The limit of detection for quantitative polymerase chain reaction ranged from 16 to 50 copies per reaction, indicating sensitivity limitations of these detection methods. Additionally, genetic alterations in the GPRC5D locus could either be acquired after CAR T-cell therapy or selected from preexisting clones, necessitating more sensitive detection methods for dynamic monitoring. DISCLOSURES: The research received support from the National Natural Science Foundation of China (82270181) and the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (21KJA320005). The authors reported having no relevant conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
